{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:14:39Z","timestamp":1792206879248,"version":"4.4.0"},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A target heart rate of 55\u201360 beats per minute is a goal for propranolol in both primary and secondary prophylaxis of variceal hemorrhage (VH). However, dose adjustments are often needed based on baseline heart rates. This study analyzed the effect of heart rate reduction from baseline with propranolol therapy on VH in patients with cirrhosis. A retrospective study was conducted on cirrhotic patients receiving propranolol for primary and secondary prophylaxis, 2008\u20132023. Patients were categorized as responders or non\u2010responders based on the achievement of a heart rate reduction of \u2265\u200925% from baseline. The primary outcome was the incidence of VH. A survival analysis with propensity score\u2010inverse probability treatment weighting was performed to associate heart rate reduction and the outcome. Among the 215 patients treated with propranolol for primary prophylaxis, 72 (33.5%) were responders and 143 (66.5%) non\u2010responders. In secondary prophylaxis, 157 patients were included, with 52 (33.1%) classified as responders and 105 (66.9%) as non\u2010responders. The median Child\u2013Pugh score was 6 (range 5\u201312) for primary and 7 (range 5\u201312) for secondary prophylaxis. Responders and non\u2010responders showed a similar incidence of VH in both primary (adjusted hazard ratio (HR) 1.70, 95% CI: 0.82\u20133.49) and secondary prophylaxis (adjusted HR 1.00, 95% CI: 0.34\u20132.90). Our analysis did not support achieving a heart rate reduction of \u2265\u200925% from baseline as a response to propranolol for the primary and secondary prophylaxis of VH in cirrhosis.<\/jats:p>","DOI":"10.1111\/cts.70192","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:39:07Z","timestamp":1741754347000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Heart Rate Reduction From Individual Baseline With Propranolol for Primary and Secondary Prophylaxis of Variceal Hemorrhage in Cirrhosis"],"prefix":"10.1111","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5665-9926","authenticated-orcid":false,"given":"Warunee","family":"Mingpun","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University  Chiang Mai Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilarat","family":"Saiyarat","sequence":"additional","affiliation":[{"name":"Pharmacy Division Maharaj Nakorn Chiang Mai Hospital  Chiang Mai Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-0348","authenticated-orcid":false,"given":"Mantiwee","family":"Nimworapan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University  Chiang Mai Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-5999","authenticated-orcid":false,"given":"Thitichaya","family":"Penthinapong","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University  Chiang Mai Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-1771","authenticated-orcid":false,"given":"Piyameth","family":"Dilokthornsakul","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University  Chiang Mai Thailand"},{"name":"Center for Medical and Health Technology Assessment (CM\u2010HTA), Department of Pharmaceutical Care, Faculty of Pharmacy Chiang Mai University  Chiang Mai Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5997"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000647"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.12.005"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15937"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80351-6"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35955"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50133"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.049"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.011"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.440"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275373"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6607"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab158"},{"key":"e_1_2_8_15_1","unstructured":"N. K.DhandandM. S.Khatkar \u201cStatulator: An Online Statistical Calculator. Sample Size Calculator for Comparing Two Independent Proportions \u201d2014 http:\/\/statulator.com\/SampleSize\/ss2P.html accessed: 28 January 2015."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105303242202"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072\u2010024\u201010649\u20107"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.16133"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000050"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2001.114062"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.70192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T06:55:18Z","timestamp":1743317718000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.70192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/cts.70192"],"URL":"https:\/\/doi.org\/10.1111\/cts.70192","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70192"}}